Processing of human beta-globin mRNA precursor to mRNA is defective in three patients with beta+-thalassemia
- PMID:6933479
- PMCID: PMC349818
- DOI: 10.1073/pnas.77.7.4287
Processing of human beta-globin mRNA precursor to mRNA is defective in three patients with beta+-thalassemia
Abstract
Nucleated bone marrow cells from normal individuals and from three patients with homozygous beta+-thalassemia were pulse-labeled with tritiated nucleosides. The processing of the newly synthesized globin mRNA precursors was monitored by inhibiting additional transcription with actinomycin D for 30 min. Human beta-globin mRNA is derived from its precursor via a series of reactions that generate processing intermediates. In nonthalassemic cells the precursor is processed efficiently to mature mRNA during the chase. In contrast, in beta+-thalassemic cells the processing of beta-globin RNA is defective. In one patient the beta-globin mRNA precursor turns over during the chase, but some of the intermediate RNAs accumulate and are not processed to mRNA. In two other patients a large fraction of the precursor and intermediate RNAs is not processed to mRNA. The alpha-globin mRNA precursor and intermediates are processed efficiently to mRNA-sized molecules in thalassemic and normal cells. The reduction in the rate of beta-globin but not alpha-globin RNA processing accounts for the alpha/beta globin mRNA imbalance in thalassemic erythroid cells. We discuss the possibility that the genetic lesions in beta+-thalassemia are at splicing signal sites within intervening sequences of the beta-globin gene.
Similar articles
- Posttranscriptional defects in beta-globin messenger RNA metabolism in beta-thalassemia: abnormal accumulation of beta-messenger RNA precursor sequences.Benz EJ Jr, Scarpa AL, Tonkonow BL, Pearson HA, Ritchey AK.Benz EJ Jr, et al.J Clin Invest. 1981 Dec;68(6):1529-38. doi: 10.1172/jci110407.J Clin Invest. 1981.PMID:7320200Free PMC article.
- Base substitution in an intervening sequence of a beta+-thalassemic human globin gene.Spritz RA, Jagadeeswaran P, Choudary PV, Biro PA, Elder JT, deRiel JK, Manley JL, Gefter ML, Forget BG, Weissman SM.Spritz RA, et al.Proc Natl Acad Sci U S A. 1981 Apr;78(4):2455-9. doi: 10.1073/pnas.78.4.2455.Proc Natl Acad Sci U S A. 1981.PMID:6264477Free PMC article.
- Unstable beta-globin mRNA in mRNA-deficient beta o thalassemia.Maquat LE, Kinniburgh AJ, Rachmilewitz EA, Ross J.Maquat LE, et al.Cell. 1981 Dec;27(3 Pt 2):543-53. doi: 10.1016/0092-8674(81)90396-2.Cell. 1981.PMID:6101206
- Globin mRNA in Friend cells: its structure, function and synthesis.Curtis PJ.Curtis PJ.Biochim Biophys Acta. 1980 Sep 22;605(3):347-64. doi: 10.1016/0304-419x(80)90016-5.Biochim Biophys Acta. 1980.PMID:6996728Review.
- Genome activity and gene expression in avian erythroid cells.Gasaryan KG.Gasaryan KG.Int Rev Cytol. 1982;74:95-126. doi: 10.1016/s0074-7696(08)61170-5.Int Rev Cytol. 1982.PMID:6181005Review.No abstract available.
Cited by
- β-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies.Rivella S.Rivella S.Haematologica. 2015 Apr;100(4):418-30. doi: 10.3324/haematol.2014.114827.Haematologica. 2015.PMID:25828088Free PMC article.Review.
- A beta zero-thalassemic beta-globin RNA that is labile in bone marrow cells is relatively stable in HeLa cells.Maquat LE, Kinniburgh AJ.Maquat LE, et al.Nucleic Acids Res. 1985 Apr 25;13(8):2855-67. doi: 10.1093/nar/13.8.2855.Nucleic Acids Res. 1985.PMID:2582366Free PMC article.
- Purkinje cell degeneration associated with erythroid ankyrin deficiency in nb/nb mice.Peters LL, Birkenmeier CS, Bronson RT, White RA, Lux SE, Otto E, Bennett V, Higgins A, Barker JE.Peters LL, et al.J Cell Biol. 1991 Sep;114(6):1233-41. doi: 10.1083/jcb.114.6.1233.J Cell Biol. 1991.PMID:1716634Free PMC article.
- Nucleocytoplasmic RNA transport.Clawson GA, Feldherr CM, Smuckler EA.Clawson GA, et al.Mol Cell Biochem. 1985 Jul;67(2):87-99. doi: 10.1007/BF02370167.Mol Cell Biochem. 1985.PMID:2413344Review.
- Abnormal splice in a mutant human beta-globin gene not at the site of a mutation.Dobkin C, Pergolizzi RG, Bahre P, Bank A.Dobkin C, et al.Proc Natl Acad Sci U S A. 1983 Mar;80(5):1184-8. doi: 10.1073/pnas.80.5.1184.Proc Natl Acad Sci U S A. 1983.PMID:6298782Free PMC article.
References
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Medical